Phreesia Stock (NYSE: PHR) stock price, news, charts, stock research, profile.
Open | $21.960 |
Close | $21.370 |
Volume / Avg. | 236.569K / 491.607K |
Day Range | 21.000 - 21.960 |
52 Wk Range | 12.050 - 34.979 |
Market Cap | $1.205B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 43 |
Short Interest | 4.99% |
Days to Cover | 4.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Phreesia (NYSE: PHR) through any online brokerage.
Other companies in Phreesia’s space includes: MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX), Definitive Healthcare (NASDAQ:DH) and TruBridge (NASDAQ:TBRG).
The latest price target for Phreesia (NYSE: PHR) was reported by Stephens & Co. on Friday, March 22, 2024. The analyst firm set a price target for 28.00 expecting PHR to rise to within 12 months (a possible 31.02% upside). 35 analyst firms have reported ratings in the last year.
The stock price for Phreesia (NYSE: PHR) is $21.37 last updated May 10, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $0.58 per share of Class A Common Stock. The quarterly cash dividend was payable on December 18, 2014 to stockholders of record on November 21, 2014.
Phreesia’s Q1 earnings are confirmed for Thursday, May 30, 2024.
There is no upcoming split for Phreesia.
Phreesia is in the Health Care sector and Health Care Technology industry. They are listed on the NYSE.